Novo Integrated Sciences appoints Robert Oliva as President to enhance operational efficiency and drive growth in product-based business units.

Novo Integrated Sciences (NVOS) has named Robert Oliva as their new President, taking over from Christopher David who continues as COO and Board of Directors member. With over 35 years of experience in business development and manufacturing operations, Oliva is expected to improve the company's operational efficiency and manage sustainable growth. CEO Robert Mattacchione praised Oliva's experience, stating it will aid in accelerating growth in the company's product-based business unit. Novo Integrated Sciences focuses on a patient-first approach to healthcare through a multidisciplinary ecosystem combining medical technology, advanced therapeutics, and rehabilitative science.

February 16, 2024
4 Articles

Further Reading